Skip to main content

Month: September 2023

Uponor Corporation – Managers’ transactions: Markus Melkko

Uponor Corporation, Managers’ Transactions, 29 September 2023 at 11:45 am EET Uponor Corporation – Managers’ transactions: Markus Melkko Transaction notification under Article 19 of EU Market Abuse Regulation. Person subject to the notification requirementName: Markus MelkkoPosition: Chief Financial OfficerIssuer: Uponor CorporationLEI: 743700KA2GMSYJM3CM12 Notification type: INITIAL NOTIFICATIONReference number: 39556/5/4____________________________________________ Transaction date: 2023-09-28Outside a trading venueInstrument type: SHAREISIN: FI0009002158Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 5,481 Unit price: 0.00 EUR Aggregated transactions(1): Volume: 5,481 Volume weighted average price: 0.00 EUR Further information:Franciska JanzonSenior Vice President, Corporate Communications...

Continue reading

Uponor Corporation – Managers’ transactions: Michael Rauterkus

Uponor Corporation, Managers’ Transactions, 29 September 2023 at 11:40 am EET Uponor Corporation – Managers’ transactions: Michael Rauterkus Transaction notification under Article 19 of EU Market Abuse Regulation. Person subject to the notification requirementName: Michael RauterkusPosition: Chief Executive OfficerIssuer: Uponor CorporationLEI: 743700KA2GMSYJM3CM12 Notification type: INITIAL NOTIFICATIONReference number: 39557/5/4____________________________________________ Transaction date: 2023-09-28Outside a trading venueInstrument type: SHAREISIN: FI0009002158Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 22,106 Unit price: 0.00 EUR Aggregated transactions(1): Volume: 22,106 Volume weighted average price: 0.00 EUR Further information:Franciska JanzonSenior Vice President, Corporate Communications...

Continue reading

ForFarmers N.V.: Approval from competition authority for sale of ForFarmers’ Belgian compound feed activities to Arvesta

Lochem, 29 September 2023                            Approval from competition authority for sale of ForFarmers’ Belgian compound feed activities to Arvesta The Belgian competition authority has today approved the sale by ForFarmers of its compound feed activities to Arvesta. This transaction, as announced on 4 April 2023, means that Arvesta takes over the compound feed activities, the employees, the production site in Izegem and the mill in Ingelmunster in West Flanders from ForFarmers. ForFarmers’ sale activities regarding co-products, organic feed by Reudink and horse feed by Pavo are excluded from this transaction. The transaction will be closed by mid-October, when ForFarmers will receive a net amount of €25 million in cash from Arvesta as agreed in the sale / purchase agreement. This transaction fits in with ForFarmers’...

Continue reading

Cornish Metals Releases Unaudited Financial Statements and Management’s Discussion and Analysis for the Six Months Ended 31 July 2023

VANCOUVER, British Columbia, Sept. 29, 2023 (GLOBE NEWSWIRE) — Cornish Metals Inc. (TSX-V/AIM: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on its projects in Cornwall, United Kingdom, is pleased to announce that it has released its unaudited financial statements and management, discussion and analysis (“MD&A”) for the six months ended July 31, 2023. The reports are available under the Company’s profile on SEDAR (www.sedar.com) and on the Company’s website (www.cornishmetals.com). Highlights for the six months ended July 31, 2023 and for the period ending September 28, 2023 (All figures expressed in Canadian dollars unless otherwise stated)Updated JORC (2012) compliant Mineral Resource Estimate for South Crofty mine released showing a 31.6% increase to contained tin in...

Continue reading

Spexis provides business update and announces financial results for the first half of 2023

Ad hoc announcement pursuant to Art. 53 LRBalixafortide, a potent CXCR4 inhibitor, to be evaluated for the treatment of pancreatic ductal adenocarcinoma (PDAC) Spexis closed capital commitments totaling USD $7.5 million supporting Phase 3 ColiFin® program in cystic fibrosis (CF) infections COPILOT study expected to initiate in fourth quarter 2023 Appointed Gonçalo Bernardes, PhD, as acting Head of Chemical Biology Announced strong safety and pharmacokinetics results from first-in-human study with inhaled murepavadin, a novel macrocycle compound Engaged Maxim Group LLC as M&A advisor to evaluate strategic transactions of which Spexis would be the surviving company Business update conference call to be held in OctoberALLSCHWIL, Switzerland, Sept. 28, 2023 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical...

Continue reading

McPhy Energy: McPhy commissions the first large-capacity and low-carbon hydrogen refueling station for Brétéché in Vendée (AVIA network)

Brétéché inaugurates the first station in its low-carbon hydrogen distribution network at Maché in Vendée (France) This Dual Pressure 350 and 700 bar station, with a capacity of up to 1 ton per day, will supply hydrogen to light, commercial and then heavy vehicles for professionals and private customers With this new reference, McPhy supports Brétéché in its decarbonization initiatives and strengthens its position in the hydrogen mobility segmentGrenoble, September 29, 2023 – 7:45 am CEST – McPhy Energy, specialized in low-carbon hydrogen production and distribution equipment (electrolyzers and refueling stations), today announces the inauguration and commissioning of a Dual Pressure hydrogen station for Brétéché, petroleum products distributor and subsidiary of France’s leading independent petroleum network, AVIA...

Continue reading

Virtualware’s VIROO capabilities shown at NATO Exercise

Bilbao, Spain, September 29.- Virtualware (EPA: MLVIR), the European leader in the virtual reality industry, has participated at the NATO Air Operation exercise focused on chemical, biological, radiological, and nuclear (CBRN) Def interoperability to present the VR training project for the Spanish Health Forces. The Koksijde air base, in West Flanders, in Belgium has hosted this large-scale NATO (CBRN) defense exercise called Toxic Trip 2023, from Saturday September 23 to Friday September 29, that brought together 600 military personnel. Specialist from 18 NATO countries (including Belgium, Bulgaria, Canada, Denmark, France, Germany, Hungary, Italy, Lithuania, the Netherlands, Romania, Spain, Turkey, the United Kingdom and the United States) practiced and tested passive defense and CBRN techniques and procedures. The aim was to enhance...

Continue reading

CFO Samuel Künzli to leave Feintool by the end of March 2024

Ad hoc announcement pursuant to Art. 53 LR Samuel Künzli will step down as Feintool Chief Financial Officer and member of the executive board at the end of March 2024 to pursue a new challenge outside the company. Over the past three years, Samuel Künzli has played a significant role in the transformation of the Feintool Group, with a particular focus on Green Energy, leading to important achievements and milestones. The board of directors and executive management team at the Feintool Group extend their gratitude to Samuel Künzli for the successful collaboration during his tenure and wish him all the best in his future endeavors. The succession process will commence immediately. Alexander von Witzleben, Chairman of the Feintool Board of Directors, stated: “We regret that Samuel Künzli is leaving our company. As Chief Financial Officer,...

Continue reading

High Arctic Provides Reorganization and PNG Update

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) — High Arctic Energy Services Inc. (TSX: HWO) “High Arctic” or the “Corporation” provides an update on the contemplated reorganization of the Corporation, including the associated tax efficient $38.2 million return of capital, the Papua New Guinea focused business spin-out to shareholders, refocus of the Canadian business and an update on its Papua New Guinea (“PNG”) operations. The Corporation has received feedback from shareholders and is working with its advisors on the reorganization plan to incorporate key elements of the shareholder feedback. The High Arctic board has reserved...

Continue reading

Madrigal Pharmaceuticals Announces Pricing of $500 Million Public Offering

CONSHOHOCKEN, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced the pricing of its underwritten public offering of 1,248,098 shares of its common stock at a public offering price of $151.69 per share, and, to certain investors, pre-funded warrants to purchase 2,048,098 shares of common stock at a price of $151.6899 per pre-funded warrant, which represents the per share public offering price for the common stock less the $0.0001 per share exercise price for each such pre-funded warrant. The gross proceeds to Madrigal from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses, are expected to be approximately $500...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.